These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 444362)

  • 1. Plasma salicylate levels after soluble and effervescent aspirin.
    Orton D; Treharne Jones R; Kaspi T; Richardson R
    Br J Clin Pharmacol; 1979 Apr; 7(4):410-2. PubMed ID: 444362
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
    Wiseman EH
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced absorption of salicylate from Safapyryn-Co tablets.
    Bradbrook ID; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1979 Oct; 8(4):371-2. PubMed ID: 508513
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of aspirin formulation and dose on concentration of total salicylate in rat kidney.
    Leeling JL; Phillips BM; Kowalski TL; Kowalski RL
    J Pharm Sci; 1976 Mar; 65(3):447-50. PubMed ID: 1263101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
    Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
    Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum salicylate concentrations after aspirin administration at 6- or 12-hour intervals.
    Butler CD; Straughn AB
    Clin Pharm; 1982; 1(5):458-60. PubMed ID: 7184679
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary pH and plasma levels of salicylate after administration of different buffered acetylsalicylic acid formulations.
    Bogentoft C; Dahl G; Magnusson A
    Biopharm Drug Dispos; 1983; 4(2):137-43. PubMed ID: 6882881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management.
    Bogacz K; Caldron P
    Am J Med; 1987 Oct; 83(4):783-6. PubMed ID: 2823600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 12. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma salicylate levels in rheumatoid arthritis: a comparison between micro-encapsulated and conventional aspirin.
    Hanson A; Lindroth Y; Sjöblom KG; Wollheim FA
    Scand J Rheumatol; 1979; 8(2):106-8. PubMed ID: 451489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on aspirin absorption from tablets and buffered solutions.
    Mason WD; Winer N
    J Pharm Sci; 1983 Jul; 72(7):819-21. PubMed ID: 6886992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions.
    Mason WD
    J Pharm Sci; 1984 Jul; 73(7):998-9. PubMed ID: 6470971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of plasma salicylate concentration to urinary salicylate excretion-rate.
    CUMMINGS AJ; MARTIN BK
    Nature; 1962 Sep; 195():1104-5. PubMed ID: 13882616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.